[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Structural Heart Disease Intervention Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

April 2023 | 109 pages | ID: GDA23B1D1B4EEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Structural Heart Disease Intervention Devices market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Structural heart disease intervention devices are medical devices used to treat heart diseases by repairing or replacing diseased or defective heart tissues or structures through minimally invasive procedures. Common types of structural heart disease intervention devices include:

Atrial septal defect closure devices: used to treat congenital heart defects by inserting a device into the heart through a catheter and placing a closure device over the defect to prevent blood from flowing from the left atrium to the right atrium.

Mitral valve repair devices: used to treat mitral valve regurgitation or prolapse by inserting a device into the heart through a catheter and placing a repair device over the damaged or prolapsed valve.

Transcatheter aortic valve replacement devices: used to treat aortic valve stenosis or regurgitation by inserting an artificial valve into the heart through a catheter and replacing the damaged aortic valve.

Cerebral aneurysm coiling devices: used to treat cerebral aneurysms or narrowing of the blood vessels in the brain by inserting a coil into the blood vessel through a catheter to strengthen the blood vessel and prevent blood from leaking out.

These structural heart disease intervention devices have been widely used in clinical practice and have achieved good treatment results, significantly improving the cardiovascular function of patients and enhancing their quality of life.

This report is a detailed and comprehensive analysis for global Structural Heart Disease Intervention Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Structural Heart Disease Intervention Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Structural Heart Disease Intervention Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Structural Heart Disease Intervention Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029

Global Structural Heart Disease Intervention Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Structural Heart Disease Intervention Devices

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Structural Heart Disease Intervention Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Structural Heart, Philips, Japen Lifeline, Neovasc and Append Medical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Structural Heart Disease Intervention Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Atrial Interventional Class
  • Cardiovascular Intervention
Market segment by Application
  • Congenital Heart Disease Treatment
  • Valvular Heart Disease Treatment
  • Cardiomyopathy Treatment
  • Aneurysm and Arterial Valve Disease Treatment
  • Others
Major players covered
  • Abbott Structural Heart
  • Philips
  • Japen Lifeline
  • Neovasc
  • Append Medical
  • Transverse Medical
  • Cardiomech
  • Thubrikar Aortic Valve Inc
  • Boston Scientific
  • Edwards Lifesciences Corporation
  • Biomerics
  • LivaNova PLC
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Structural Heart Disease Intervention Devices product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Structural Heart Disease Intervention Devices, with price, sales, revenue and global market share of Structural Heart Disease Intervention Devices from 2018 to 2023.

Chapter 3, the Structural Heart Disease Intervention Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Structural Heart Disease Intervention Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Structural Heart Disease Intervention Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Structural Heart Disease Intervention Devices.

Chapter 14 and 15, to describe Structural Heart Disease Intervention Devices sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Structural Heart Disease Intervention Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Structural Heart Disease Intervention Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Atrial Interventional Class
  1.3.3 Cardiovascular Intervention
1.4 Market Analysis by Application
  1.4.1 Overview: Global Structural Heart Disease Intervention Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Congenital Heart Disease Treatment
  1.4.3 Valvular Heart Disease Treatment
  1.4.4 Cardiomyopathy Treatment
  1.4.5 Aneurysm and Arterial Valve Disease Treatment
  1.4.6 Others
1.5 Global Structural Heart Disease Intervention Devices Market Size & Forecast
  1.5.1 Global Structural Heart Disease Intervention Devices Consumption Value (2018 & 2022 & 2029)
  1.5.2 Global Structural Heart Disease Intervention Devices Sales Quantity (2018-2029)
  1.5.3 Global Structural Heart Disease Intervention Devices Average Price (2018-2029)

2 MANUFACTURERS PROFILES

2.1 Abbott Structural Heart
  2.1.1 Abbott Structural Heart Details
  2.1.2 Abbott Structural Heart Major Business
  2.1.3 Abbott Structural Heart Structural Heart Disease Intervention Devices Product and Services
  2.1.4 Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Abbott Structural Heart Recent Developments/Updates
2.2 Philips
  2.2.1 Philips Details
  2.2.2 Philips Major Business
  2.2.3 Philips Structural Heart Disease Intervention Devices Product and Services
  2.2.4 Philips Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Philips Recent Developments/Updates
2.3 Japen Lifeline
  2.3.1 Japen Lifeline Details
  2.3.2 Japen Lifeline Major Business
  2.3.3 Japen Lifeline Structural Heart Disease Intervention Devices Product and Services
  2.3.4 Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Japen Lifeline Recent Developments/Updates
2.4 Neovasc
  2.4.1 Neovasc Details
  2.4.2 Neovasc Major Business
  2.4.3 Neovasc Structural Heart Disease Intervention Devices Product and Services
  2.4.4 Neovasc Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Neovasc Recent Developments/Updates
2.5 Append Medical
  2.5.1 Append Medical Details
  2.5.2 Append Medical Major Business
  2.5.3 Append Medical Structural Heart Disease Intervention Devices Product and Services
  2.5.4 Append Medical Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 Append Medical Recent Developments/Updates
2.6 Transverse Medical
  2.6.1 Transverse Medical Details
  2.6.2 Transverse Medical Major Business
  2.6.3 Transverse Medical Structural Heart Disease Intervention Devices Product and Services
  2.6.4 Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 Transverse Medical Recent Developments/Updates
2.7 Cardiomech
  2.7.1 Cardiomech Details
  2.7.2 Cardiomech Major Business
  2.7.3 Cardiomech Structural Heart Disease Intervention Devices Product and Services
  2.7.4 Cardiomech Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 Cardiomech Recent Developments/Updates
2.8 Thubrikar Aortic Valve Inc
  2.8.1 Thubrikar Aortic Valve Inc Details
  2.8.2 Thubrikar Aortic Valve Inc Major Business
  2.8.3 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product and Services
  2.8.4 Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 Thubrikar Aortic Valve Inc Recent Developments/Updates
2.9 Boston Scientific
  2.9.1 Boston Scientific Details
  2.9.2 Boston Scientific Major Business
  2.9.3 Boston Scientific Structural Heart Disease Intervention Devices Product and Services
  2.9.4 Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Boston Scientific Recent Developments/Updates
2.10 Edwards Lifesciences Corporation
  2.10.1 Edwards Lifesciences Corporation Details
  2.10.2 Edwards Lifesciences Corporation Major Business
  2.10.3 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product and Services
  2.10.4 Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Edwards Lifesciences Corporation Recent Developments/Updates
2.11 Biomerics
  2.11.1 Biomerics Details
  2.11.2 Biomerics Major Business
  2.11.3 Biomerics Structural Heart Disease Intervention Devices Product and Services
  2.11.4 Biomerics Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Biomerics Recent Developments/Updates
2.12 LivaNova PLC
  2.12.1 LivaNova PLC Details
  2.12.2 LivaNova PLC Major Business
  2.12.3 LivaNova PLC Structural Heart Disease Intervention Devices Product and Services
  2.12.4 LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 LivaNova PLC Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: STRUCTURAL HEART DISEASE INTERVENTION DEVICES BY MANUFACTURER

3.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Structural Heart Disease Intervention Devices Revenue by Manufacturer (2018-2023)
3.3 Global Structural Heart Disease Intervention Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
  3.4.1 Producer Shipments of Structural Heart Disease Intervention Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
  3.4.2 Top 3 Structural Heart Disease Intervention Devices Manufacturer Market Share in 2022
  3.4.2 Top 6 Structural Heart Disease Intervention Devices Manufacturer Market Share in 2022
3.5 Structural Heart Disease Intervention Devices Market: Overall Company Footprint Analysis
  3.5.1 Structural Heart Disease Intervention Devices Market: Region Footprint
  3.5.2 Structural Heart Disease Intervention Devices Market: Company Product Type Footprint
  3.5.3 Structural Heart Disease Intervention Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Structural Heart Disease Intervention Devices Market Size by Region
  4.1.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2029)
  4.1.2 Global Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2029)
  4.1.3 Global Structural Heart Disease Intervention Devices Average Price by Region (2018-2029)
4.2 North America Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.3 Europe Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.5 South America Structural Heart Disease Intervention Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Structural Heart Disease Intervention Devices Consumption Value (2018-2029)

5 MARKET SEGMENT BY TYPE

5.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
5.2 Global Structural Heart Disease Intervention Devices Consumption Value by Type (2018-2029)
5.3 Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2029)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
6.2 Global Structural Heart Disease Intervention Devices Consumption Value by Application (2018-2029)
6.3 Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2029)

7 NORTH AMERICA

7.1 North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
7.2 North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
7.3 North America Structural Heart Disease Intervention Devices Market Size by Country
  7.3.1 North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
  7.3.2 North America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
  7.3.3 United States Market Size and Forecast (2018-2029)
  7.3.4 Canada Market Size and Forecast (2018-2029)
  7.3.5 Mexico Market Size and Forecast (2018-2029)

8 EUROPE

8.1 Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
8.2 Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
8.3 Europe Structural Heart Disease Intervention Devices Market Size by Country
  8.3.1 Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
  8.3.2 Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
  8.3.3 Germany Market Size and Forecast (2018-2029)
  8.3.4 France Market Size and Forecast (2018-2029)
  8.3.5 United Kingdom Market Size and Forecast (2018-2029)
  8.3.6 Russia Market Size and Forecast (2018-2029)
  8.3.7 Italy Market Size and Forecast (2018-2029)

9 ASIA-PACIFIC

9.1 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Structural Heart Disease Intervention Devices Market Size by Region
  9.3.1 Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2029)
  9.3.2 Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2029)
  9.3.3 China Market Size and Forecast (2018-2029)
  9.3.4 Japan Market Size and Forecast (2018-2029)
  9.3.5 Korea Market Size and Forecast (2018-2029)
  9.3.6 India Market Size and Forecast (2018-2029)
  9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
  9.3.8 Australia Market Size and Forecast (2018-2029)

10 SOUTH AMERICA

10.1 South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
10.2 South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
10.3 South America Structural Heart Disease Intervention Devices Market Size by Country
  10.3.1 South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
  10.3.2 South America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
  10.3.3 Brazil Market Size and Forecast (2018-2029)
  10.3.4 Argentina Market Size and Forecast (2018-2029)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Structural Heart Disease Intervention Devices Market Size by Country
  11.3.1 Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2029)
  11.3.2 Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2029)
  11.3.3 Turkey Market Size and Forecast (2018-2029)
  11.3.4 Egypt Market Size and Forecast (2018-2029)
  11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
  11.3.6 South Africa Market Size and Forecast (2018-2029)

12 MARKET DYNAMICS

12.1 Structural Heart Disease Intervention Devices Market Drivers
12.2 Structural Heart Disease Intervention Devices Market Restraints
12.3 Structural Heart Disease Intervention Devices Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
  12.5.1 Influence of COVID-19
  12.5.2 Influence of Russia-Ukraine War

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Structural Heart Disease Intervention Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Structural Heart Disease Intervention Devices
13.3 Structural Heart Disease Intervention Devices Production Process
13.4 Structural Heart Disease Intervention Devices Industrial Chain

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Structural Heart Disease Intervention Devices Typical Distributors
14.3 Structural Heart Disease Intervention Devices Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

LIST OF TABLES

Table 1. Global Structural Heart Disease Intervention Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Structural Heart Disease Intervention Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Abbott Structural Heart Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Structural Heart Major Business
Table 5. Abbott Structural Heart Structural Heart Disease Intervention Devices Product and Services
Table 6. Abbott Structural Heart Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Abbott Structural Heart Recent Developments/Updates
Table 8. Philips Basic Information, Manufacturing Base and Competitors
Table 9. Philips Major Business
Table 10. Philips Structural Heart Disease Intervention Devices Product and Services
Table 11. Philips Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Philips Recent Developments/Updates
Table 13. Japen Lifeline Basic Information, Manufacturing Base and Competitors
Table 14. Japen Lifeline Major Business
Table 15. Japen Lifeline Structural Heart Disease Intervention Devices Product and Services
Table 16. Japen Lifeline Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Japen Lifeline Recent Developments/Updates
Table 18. Neovasc Basic Information, Manufacturing Base and Competitors
Table 19. Neovasc Major Business
Table 20. Neovasc Structural Heart Disease Intervention Devices Product and Services
Table 21. Neovasc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Neovasc Recent Developments/Updates
Table 23. Append Medical Basic Information, Manufacturing Base and Competitors
Table 24. Append Medical Major Business
Table 25. Append Medical Structural Heart Disease Intervention Devices Product and Services
Table 26. Append Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Append Medical Recent Developments/Updates
Table 28. Transverse Medical Basic Information, Manufacturing Base and Competitors
Table 29. Transverse Medical Major Business
Table 30. Transverse Medical Structural Heart Disease Intervention Devices Product and Services
Table 31. Transverse Medical Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Transverse Medical Recent Developments/Updates
Table 33. Cardiomech Basic Information, Manufacturing Base and Competitors
Table 34. Cardiomech Major Business
Table 35. Cardiomech Structural Heart Disease Intervention Devices Product and Services
Table 36. Cardiomech Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Cardiomech Recent Developments/Updates
Table 38. Thubrikar Aortic Valve Inc Basic Information, Manufacturing Base and Competitors
Table 39. Thubrikar Aortic Valve Inc Major Business
Table 40. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Product and Services
Table 41. Thubrikar Aortic Valve Inc Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Thubrikar Aortic Valve Inc Recent Developments/Updates
Table 43. Boston Scientific Basic Information, Manufacturing Base and Competitors
Table 44. Boston Scientific Major Business
Table 45. Boston Scientific Structural Heart Disease Intervention Devices Product and Services
Table 46. Boston Scientific Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Boston Scientific Recent Developments/Updates
Table 48. Edwards Lifesciences Corporation Basic Information, Manufacturing Base and Competitors
Table 49. Edwards Lifesciences Corporation Major Business
Table 50. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Product and Services
Table 51. Edwards Lifesciences Corporation Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Edwards Lifesciences Corporation Recent Developments/Updates
Table 53. Biomerics Basic Information, Manufacturing Base and Competitors
Table 54. Biomerics Major Business
Table 55. Biomerics Structural Heart Disease Intervention Devices Product and Services
Table 56. Biomerics Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Biomerics Recent Developments/Updates
Table 58. LivaNova PLC Basic Information, Manufacturing Base and Competitors
Table 59. LivaNova PLC Major Business
Table 60. LivaNova PLC Structural Heart Disease Intervention Devices Product and Services
Table 61. LivaNova PLC Structural Heart Disease Intervention Devices Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. LivaNova PLC Recent Developments/Updates
Table 63. Global Structural Heart Disease Intervention Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Structural Heart Disease Intervention Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Structural Heart Disease Intervention Devices Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Structural Heart Disease Intervention Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Structural Heart Disease Intervention Devices Production Site of Key Manufacturer
Table 68. Structural Heart Disease Intervention Devices Market: Company Product Type Footprint
Table 69. Structural Heart Disease Intervention Devices Market: Company Product Application Footprint
Table 70. Structural Heart Disease Intervention Devices New Market Entrants and Barriers to Market Entry
Table 71. Structural Heart Disease Intervention Devices Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Structural Heart Disease Intervention Devices Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Structural Heart Disease Intervention Devices Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Structural Heart Disease Intervention Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Structural Heart Disease Intervention Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Structural Heart Disease Intervention Devices Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Structural Heart Disease Intervention Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Structural Heart Disease Intervention Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Structural Heart Disease Intervention Devices Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Structural Heart Disease Intervention Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Structural Heart Disease Intervention Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Structural Heart Disease Intervention Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Structural Heart Disease Intervention Devices Raw Material
Table 131. Key Manufacturers of Structural Heart Disease Intervention Devices Raw Materials
Table 132. Structural Heart Disease Intervention Devices Typical Distributors
Table 133. Structural Heart Disease Intervention Devices Typical Customers

LIST OF FIGURES

Figure 1. Structural Heart Disease Intervention Devices Picture
Figure 2. Global Structural Heart Disease Intervention Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Type in 2022
Figure 4. Atrial Interventional Class Examples
Figure 5. Cardiovascular Intervention Examples
Figure 6. Global Structural Heart Disease Intervention Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Application in 2022
Figure 8. Congenital Heart Disease Treatment Examples
Figure 9. Valvular Heart Disease Treatment Examples
Figure 10. Cardiomyopathy Treatment Examples
Figure 11. Aneurysm and Arterial Valve Disease Treatment Examples
Figure 12. Others Examples
Figure 13. Global Structural Heart Disease Intervention Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Structural Heart Disease Intervention Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Structural Heart Disease Intervention Devices Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Structural Heart Disease Intervention Devices Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Structural Heart Disease Intervention Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Structural Heart Disease Intervention Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Structural Heart Disease Intervention Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Structural Heart Disease Intervention Devices Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Structural Heart Disease Intervention Devices Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Structural Heart Disease Intervention Devices Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 55. China Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Structural Heart Disease Intervention Devices Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Structural Heart Disease Intervention Devices Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Structural Heart Disease Intervention Devices Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Structural Heart Disease Intervention Devices Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Structural Heart Disease Intervention Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Structural Heart Disease Intervention Devices Market Drivers
Figure 76. Structural Heart Disease Intervention Devices Market Restraints
Figure 77. Structural Heart Disease Intervention Devices Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Structural Heart Disease Intervention Devices in 2022
Figure 80. Manufacturing Process Analysis of Structural Heart Disease Intervention Devices
Figure 81. Structural Heart Disease Intervention Devices Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


More Publications